CUFinder

Emily Costa

Emily Costa

Cornell University

H-index: 5

North America-United States

Contact Emily Costa

About Emily Costa

Emily Costa, With an exceptional h-index of 5 and a recent h-index of 5 (since 2020), a distinguished researcher at Cornell University, specializes in the field of lung adenocarcinoma, chromatin remodeling, CRISPR/Cas9, cancer models, metastasis.

His recent articles reflect a diverse array of research interests and contributions to the field:

228P SMARCA4 inactivation drives aggressiveness in STK11/KEAP1 co-mutant lung adenocarcinomas through the induction of TGFβ signaling

STAT3-driven MAPK activation represents a therapeutic vulnerability in ASCL1 high SCLC

Characterizing SMARCA4/STK11/KEAP1 co-mutant lung adenocarcinoma

Rlf–Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer

MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer

Abstract LB186: MAPK pathway activation represents a therapeutic vulnerability in ASCL1-driven SCLC

Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid in vivo functional genomics

Emily Costa Information

University

Position

PhD Candidate, Weill Cornell Graduate School of Medical Sciences

Citations(all)

200

Citations(since 2020)

198

Cited By

50

hIndex(all)

5

hIndex(since 2020)

5

i10Index(all)

5

i10Index(since 2020)

5

Email

University Profile Page

Google Scholar

Emily Costa Skills & Research Interests

lung adenocarcinoma

chromatin remodeling

CRISPR/Cas9

cancer models

metastasis

Top articles of Emily Costa

228P SMARCA4 inactivation drives aggressiveness in STK11/KEAP1 co-mutant lung adenocarcinomas through the induction of TGFβ signaling

ESMO Open

2024/3/1

STAT3-driven MAPK activation represents a therapeutic vulnerability in ASCL1 high SCLC

Cancer Research

2022/6/15

Emily Costa
Emily Costa

H-Index: 3

Xiaoping Chen
Xiaoping Chen

H-Index: 2

Characterizing SMARCA4/STK11/KEAP1 co-mutant lung adenocarcinoma

Cancer Research

2022/6/15

Emily Costa
Emily Costa

H-Index: 3

Rlf–Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer

Cancer discovery

2021/12/1

Andrea Ventura
Andrea Ventura

H-Index: 2

MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer

Iscience

2021/11/19

Emily Costa
Emily Costa

H-Index: 3

Xiaoping Chen
Xiaoping Chen

H-Index: 2

Abstract LB186: MAPK pathway activation represents a therapeutic vulnerability in ASCL1-driven SCLC

Cancer Research

2021/7/1

Emily Costa
Emily Costa

H-Index: 3

Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid in vivo functional genomics

Nature cancer

2020/3

See List of Professors in Emily Costa University(Cornell University)